cardiovascular,PCSK9 therapies

This 1-day course will cover state-of-the-art management of patients with cardiovascular risk factors. The course will highlight evidence-based recommendations for the management of patients with cardiovascular risk factors including those with co-morbidities such as diabetes, hypertension, and autoimmune conditions. The course will also review cardiovascular risk in patients with thyroid disorders, including heart failure with Graves disease, myxedema, and thyroid hormone replacement